Pacira Biosciences Inc PCRX:NASDAQ

Last Price$37.63NASDAQ Previous Close - Last Trade as of 4:00PM ET 9/16/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$28.00 (2)
Ask (Size)$58.09 (21)
Day Low / HighN/A - N/A
Volume465.6 K
  • Latest Stories
  • Commentary and Analysis
Pacira Biosciences' 2020 Earnings Projection Scaled Down
12:56AM ET 9/17/2019 MT Newswires

The 2020 forecasted earnings estimate for Pacira Biosciences Inc's (NASDAQ:PCRX, Recent Price: 37.63) for the year ending December 31, 2020 has been scaled...

Insider Trends: Pacira Biosciences Sees 90 Days of Insider Buying Trend Reducing with Share Sale
4:18PM ET 8/16/2019 MT Newswires

On Aug 14, 2019, Chief Administrative Officer, Kristen Marie Williams, executed a sale of 6,252 shares in Pacira Biosciences (PCRX) for $246,891. After...

Consensus for Pacira Biosciences 2019 Earnings Targeted Lower but 2020 Projections Raised
7:46AM ET 8/13/2019 MT Newswires

The 2019 and 2020 full year forecasted earnings estimates for Pacira Biosciences Inc's (NASDAQ:PCRX, Recent Price: 40.39) have been changed. The consensus...

2019, 2020 Earnings Estimates for Pacira Biosciences Scaled Down
7:41AM ET 8/10/2019 MT Newswires

The full year forecasted earnings estimates for 2019 and 2020 for Pacira Biosciences Inc (NASDAQ:PCRX, Recent Price: 42.47) have been reduced. The...

--Analyst Actions: BMO Lowers Pacira Pharmaceuticals PT to $43 From $46, Keeps Market Perform Rating
2:56PM ET 8/09/2019 MT Newswires

Price: 42.67, Change: +0.31, Percent Change: +0.74 ...

Analysts' Scale Back Pacira Biosciences' 2019, 2020 Earnings Estimates
7:06AM ET 8/09/2019 MT Newswires

The full year forecasted earnings estimates for 2019 and 2020 for Pacira Biosciences Inc (NASDAQ:PCRX, Recent Price: 42.36) have been scaled down. The...

Pacira Pharmaceuticals Q2 Results Beat Estimates
9:52AM ET 8/08/2019 MT Newswires

Pacira Pharmaceuticals (PCRX) reported Q2 non-GAAP earnings of $0.41 per diluted share, up from $0.24 during the year-ago quarter and beating the Capital...

Insider Trends: Insider Sale at Pacira Biosciences Reducing 90-Days of Buying
5:50PM ET 7/12/2019 MT Newswires

David M Stack, Director and CEO & Chairman, reported a sale of 13,115 shares in Pacira Biosciences (PCRX) for $562,377 on Jul 08, 2019. Following the Form...

2019, 2020 Earnings Estimates for Pacira Biosciences Scaled Up
1:26AM ET 7/10/2019 MT Newswires

The 2019 and 2020 full year forecasted earnings estimates for Pacira Biosciences Inc's (NASDAQ:PCRX, Recent Price: 43.42) have been scaled up. The...

Pacira Pharma Says Using Its Painkiller in Wisdom Tooth Extraction Cuts Later Opioid Use
11:52AM ET 6/26/2019 MT Newswires

Pacira Pharmaceuticals' (PCRX) said its Exparel anesthetic, when given to dental patients getting wisdom teeth removed, reduced the use of post-surgery...